HCG

Peak Libido

Hormones, libido, mood.

$299 AUD · $9.97/day · 30-day supply

Lyophilised powder vial · Subcutaneous injection · Self-administered

30-day full refund if you don't notice a difference. No return required.

20,000
IU monthly protocol
Human chorionic gonadotropin
Australian Compounded
4.9 · 847 Reviews
30-Day Guarantee
Express Delivery AU-Wide

Mechanism

How РТ-141 Works.

Every other approach works on blood flow. РТ-141 works on the brain. Desire isn't vascular — it's hypothalamic.

Step 01

LH-mimetic action

 

hCG binds the LH/hCG receptor on testicular Leydig cells, stimulating your own testosterone synthesis.

Step 02

Preserves function

 

Unlike exogenous testosterone, it keeps testicular volume, the downstream hormonal cascade, and fertility intact.

Step 03

Mood & drive

 

Testosterone restoration — plus LH-receptor activity in the brain — supports libido, mood and energy.

Clinical Data

The Research.

These are РТ-141 / Вrеmеlаnоtіdе's published Phase III results — the same compound in Peak Libido.

Zucker et al. · Cureus 2022

hCG monotherapy reduced hypogonadal-symptom scores in men — directly relevant to libido, mood and energy.

PMID 35800844.

Madhusoodanan et al. · Int Braz J Urol 2019

Symptom improvement with hCG even at borderline-normal testosterone.

PMID 31408289.

Protocol

The Schedule.

РТ-141 is administered as needed, not daily. Allow 45–120 minutes for onset.

Use Case Dose Timing Onset
First use 0.75mg 45–120 min before Allow 2h — first-use onset can be slower
Standard use 1.75mg 45–90 min before Active for 6–12 hours
Frequency As needed — not for daily use. Minimum 48h between doses.
Maximum frequency 8 doses per month (per RECONNECT trial protocol)

РТ-141 protocol based on RECONNECT Phase III trial dosing and FDA-approved prescribing information for Вrеmеlаnоtіdе. As-needed use only — not for daily administration. Not medical advice. Consult a healthcare professional before use.

Customer Results

They Ran It.

10,347 Australians
4.9★ · 847 reviews
1-in-3 re-order within 60 days
★★★★★
Tried everything — and everything worked mechanically but the desire just wasn't there. A friend mentioned РТ-141. Within 90 minutes it was like my brain had remembered something it had forgotten. That's the only way I can describe it.
Name withheld — Melbourne, 44, female — Libido (РТ-141)
★★★★★
Sildenafil stopped working for me three years ago. My GP told me it was psychological. Peak Libido two hours before — everything I'd lost was back. The mechanism makes sense once you understand it isn't the same drug in a different form. It's a different problem being solved.
Name withheld — Sydney, 51, male — Libido (РТ-141)
★★★★★
I'm postmenopausal. My doctor said this was to be expected. I found РТ-141, read the RECONNECT trial myself, ordered. Three months in and I feel like myself again. Why is this not more widely known.
Name withheld — Brisbane, 57, female — Libido (РТ-141)

FAQ

Common Questions.

No — completely different mechanism. Viagra and Cialis (PDE5 inhibitors) work peripherally: they increase blood flow by inhibiting the enzyme that breaks down cGMP in smooth muscle. They require sexual arousal to work and they don't address low desire. РТ-141 works centrally — it activates melanocortin receptors in the hypothalamus, initiating the desire cascade in the brain. It's the difference between treating a symptom (insufficient blood flow) and addressing the origin (insufficient desire signal).
Yes — the primary clinical trial (RECONNECT) was conducted in women, not men. The FDA approval of Вrеmеlаnоtіdе (the branded version of РТ-141) was specifically for hypoactive sexual desire disorder (HSDD) in premenopausal women. MC4R pathways are equivalent in men and women. РТ-141 is one of the only compounds in this space with primary clinical data from female populations.
Onset is 45–120 minutes from subcutaneous administration. First use can be on the slower end of that window. The effect typically lasts 6–12 hours. Unlike PDE5 inhibitors which require arousal to initiate effect, РТ-141's central mechanism means you'll notice the desire shift before any physical response — that's the mechanism working as designed.
The most commonly reported side effect in the RECONNECT trial was transient nausea — occurring in approximately 40% of participants and typically resolving within 2 hours without intervention. Flushing (facial warmth) and mild headache were also reported. Starting at the lower 0.75mg dose on first use reduces the incidence of nausea significantly. No serious adverse events were attributed to РТ-141 in the Phase III data.
30-day full refund, no return required. РТ-141 is typically effective on the first or second use — it's not a compound that requires weeks of accumulation. If you don't notice an effect within your first 3–4 administrations over 30 days, we return your $299. We compound at the dosing levels used in the trial.
Ships as lyophilised powder in a sterile vial. Reconstitute with bacteriostatic water using a fresh syringe and needle. Administer via subcutaneous injection — the lower abdomen or flank is the most common site. Rotate injection sites session to session. Ships stable at ambient temperature; refrigerate on arrival and use reconstituted solution within 21–28 days.
Standard workplace and roadside drug screens test for recreational substances and common medications — peptides will not appear on these screens. If you compete in a WADA-sanctioned sport, verify the current prohibited list at wada-ama.org before use, as regulations update annually. We recommend confirming with your sport's governing body before any sanctioned competition.